Clinical Study of a Fluid Accommodating Intraocular Lens (IOL) Design

Launched by ALCON RESEARCH · Mar 31, 2022

Keywords

ClinConnect Summary

This clinical study is evaluating a new type of intraocular lens (IOL) designed for patients with cataracts, which are cloudy areas in the eye that can affect vision. The goal is to see how well this lens works after surgery, focusing on how it improves vision and overall eye health. The study is currently looking for participants who have been diagnosed with cataracts in both eyes and need surgery to remove them.

To be eligible for the study, participants should be able to understand and sign a consent form, attend all required study visits, and have not had certain previous eye surgeries. The study welcomes individuals of all genders aged 35 and older. If you join, you can expect to undergo routine assessments to monitor your recovery and vision improvement after receiving the new lens. This research could contribute to advancements in cataract treatment and help improve outcomes for future patients.

Gender

ALL

Eligibility criteria

• Key Inclusion Criteria:
• • Able to understand and sign an Institutional Review Board / International Ethics Committee approved informed Consent form;
• • Willing and able to attend all scheduled study visits as required by the protocol;
• • Diagnosed with bilateral cataracts requiring removal by phacoemulsification with a clear corneal incision;
• • Other protocol-specified inclusion criteria may apply.
• Key Exclusion Criteria:
• • Subjects taking medications that may affect accommodation;
• • Clinically significant eye abnormalities as specified in the protocol;
• • Previous eye surgery as specified in the protocol;
• • Other protocol-specified exclusion criteria may apply.